A5019381682- Fibromyalgia and Chronic Fatigue Syndrome Research
- Myofascial pain diagnosis and treatment
- Psychosomatic Disorders and Their Treatments
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Neurological Disease Mechanisms and Treatments
- Ginkgo biloba and Cashew Applications
- Neurological Disorders and Treatments
- Assistive Technology in Communication and Mobility
- Helicobacter pylori-related gastroenterology studies
- Eosinophilic Esophagitis
- Health, psychology, and well-being
- Pediatric Pain Management Techniques
- Neurobiology of Language and Bilingualism
- Gastroesophageal reflux and treatments
- Long-Term Effects of COVID-19
- Sleep and related disorders
- Human Health and Disease
- Dementia and Cognitive Impairment Research
- Pharmacological Effects of Natural Compounds
- Circadian rhythm and melatonin
- Language Development and Disorders
- Child and Adolescent Psychosocial and Emotional Development
- Pain Mechanisms and Treatments
- COVID-19 and Mental Health
- Musculoskeletal pain and rehabilitation
Kazan Federal University
2017-2023
Background. Recently, there has been an increase in the prevalence of gastroesophageal reflux disease (GERD) Northern Europe, North America and East Asia. However data on GERD Russian population are very limited. Aim. To determine among Russia, clinical spectrum symptoms, main drugs used for treatment, rate their administration. Materials methods. The study was conducted from November 2015 to January 2017 8 cities Russia. A survey patients over age 18 years old visiting outpatient medical...
Purpose of the study to determine effectiveness Anvifen in case insomnia and meteosensitivity as comorbid stress-induced disorders.
To determine the significance of anxiety disorder and comorbid disorders in patients with post-covid brain fog, to effectiveness GABAergic nootropic drug an anxiolytic effect - Anvifen.92 post-COVID-19 no organic damage who complain fog 12 weeks after onset COVID-19 symptoms. Group 1 (n=40; 43.4±4.5 years) were treated at home; group 2 (n=32; 44.9±5.5 a hospital without oxygen support; 3 (n=20; 45.1±4.8 support. Assessment scales: Hospital Anxiety Depression Scale (HADS), Montreal Cognitive...
Study of the effectiveness monotherapy with potassium N-acetylaminosuccinate (Cogitum) for asthenic syndrome (fatigue) in individuals, uncharacteristic somatic, neurological diseases, anxiety disorders, depression and other diseases that may interfere asthenia.Patients fatigue scores 22 or more on Fatigue Assessment Scale (FAS) were randomly divided into main group (MG) - 37 people, mean age years [21; 24] control (CG) 34 21 [19; 23]. The Trail Making Test (TMT-A TMT-B), assessment general...
Study of central sensitization (CS), insomnia and meteosensitivity in patients with coronary heart disease (CHD) admitted for a routine examination.
To determine the effectiveness of treatment anxiety disorder with Anvifen (aminophenylbutyric acid) in a short (21 days) and prolonged (60 course treatment.Patients were randomly divided into two groups: (group 1) Avifen 2). In each group, patients age subgroups: 20-40 years old (1a - n=30, mean 32 [21; 39], 2a 33 [23; 38] years) 41-70 (1b 62 [51; 67] years; 2b 60 68] years). Evaluated by: Hospital Anxiety Depression Scale (HADS); fatigue according to Russian version assessment scale (The...